When a sophisticated acquirer pays only 90% of net asset value for a business development company, it sets a price on the sector’s anxiety. BC Partners did exactly that on November 11, 2026, announcing that BCP Investment Corporation would absorb Investcorp Credit Management BDC in a stock-and-cash deal that targets total consideration equal to 90% of the target’s closing NAV. Investcorp’s management had already conceded that the fund’s small size was a problem in current conditions. This is consolidation, not rescue.
The backdrop is severe. Non-traded BDC fundraising collapsed 82% year-over-year to roughly $2 billion in Q2 2026, the lowest since late 2020, according to Stanger & Co. Retail investors also pressed for liquidity as quarterly repurchase programs hit their caps across much of the category. The MVIS US Business Development Companies index price-to-book ratio hit approximately 0.83x in late February, well below its long-term average of roughly 0.97x. Listed BDCs have been dragged into the same sentiment spiral.
The question is whether the sell-off has left any listed BDC cheap enough to buy. The answer is yes, but the right one is not the cheapest.
The Discount Trap
Blue Owl Capital Corporation (OBDC) trades near $10.97 against a Q3 net asset value of $14.32, a gap of approximately 25%. That generates a trailing yield above 12%, and OBDC’s NAV did tick higher in Q3, ending three consecutive quarterly declines. The bear case is straightforward: the portfolio carries concentrated second-lien and payment-in-kind positions, rising watch-list loans, and a 2027 debt refinancing requirement. A 25% discount is only a bargain if book value holds.
Blackstone Secured Lending Fund (BXSL) reported a Q3 NAV of $25.25 and trades at roughly 0.94x that figure. Its Q3 net investment income of $0.68 came in below the $0.77 dividend, and the board has already declared a reset to $0.60 for the quarter ending March 31, 2027 (payable in April 2027). Analysts average a $24.66 target, essentially flat from here.
Why Ares Capital Is the Buy
Ares Capital Corporation (ARCC) trades near $19.17 against a Q3 NAV of $19.31, putting it just under 1.0x book. That is not the deepest discount in the peer group. It is, however, the best-quality franchise in the sector available near book value.
At $29.2 billion across 636 portfolio companies, ARCC carries diversification no smaller BDC can match. Non-accruals at fair value were 1.4% in Q3, among the sector’s lowest. Core earnings came in at $0.46 per share against a $0.48 regular dividend. Analysts remain broadly constructive on the name, with consensus targets clustered above the current price.
The catalyst is the October 27 agreement to acquire MidCap Financial Investment Corporation in a $2.6 billion stock-and-cash deal. The transaction is expected to push ARCC’s portfolio to over $31 billion of investments at fair value, lift the portfolio company count to more than 800, and expand sponsor relationships. Management has described it as modestly accretive to core earnings per share, with closing expected in the first half of 2027.
What Could Go Wrong
ARCC’s floating-rate book earns less as rates fall, and the Fed’s path through 2027 matters more than any single deal. MFIC integration adds execution risk for a quarter or two. Credit is not standing still across the space, and broad deterioration does not stop at portfolio borders.
The BC Partners deal makes the argument in reverse. BCIC is buying scale; ICMB is being sold at a discount. ARCC sits firmly on the buying side of that equation, with a transformative deal in motion and shares sitting near a level that rarely lasts.
